Boehringer Ingelheim Investigational Site

Halifax, Nova Scotia B3H2Y9

0 studies enrolling now · 6 studies all time

What they study most

Atrial Fibrillation, Diabetes Mellitus, Type 2, Hypertension, Parkinson Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN — Completed
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients — Completed
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed
• Tiotropium / Respimat One-Year Study — Completed
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed
• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed